Tag - Raymond James

Markets

Raymond James sees Profound Medical insulated from COVID-19 fallout

Raymond James reiterated that Profound Medical (TSX:PRN; NASDAQ:PROF) remains its “analyst current favorite” and “2020 Best Pick,” saying Profound is “particularly insulated from the current economic fallout of COVID-19...

March 12, 2020

Markets

Raymond James starts Cardiol Therapeutics at OP 2; PT $5

Raymond James launched coverage of Cardiol Therapeutics (TSX:CRDL) with an “outperform 2” rating and price target of $5 (Canadian). The stock closed $4 on Jan.23. Cardiol’s therapeutic strategy is focused around the...

January 24, 2020

Markets

Raymond James starts Profound Medical at OP; PT $4

Raymond James initiated coverage of Profound Medical (TSX:PRN; OTCQX:PRFMF) with an “outperform” rating and price target of $4. The stock closed at 92 cents on Aug. 23. “With its highly experienced management team...

August 26, 2019

Executive Moves

Rahul Sarugaser joins Raymond James’ life sciences research team

Rahul Sarugaser Rahul Sarugaser has joined Raymond James’ Canadian equity research team as managing director, equity analyst, healthcare, biotechnology & cannabis. Most recently, Mr. Sarugaser was an equities...

July 12, 2019

Executive Moves

Raymond James names Andrew Gitkin as co-head of health care investment banking

Raymond James named finance professional, Andrew Gitkin, as managing director and co-head of the firm’s health care investment banking practice, along side managing director, Riley Sweat.

June 7, 2019

Executive Moves

Raymond James names Dane Leone as a managing director in biotech research

Raymond James appointed Dane Leone as a managing director responsible for biotechnology coverage in the firm’s equity research department.

October 1, 2018

Tag - Raymond James

Raymond James sees Profound Medical insulated from COVID-19 fallout

Raymond James starts Cardiol Therapeutics at OP 2; PT $5

Raymond James starts Profound Medical at OP; PT $4

Rahul Sarugaser joins Raymond James’ life sciences research team

Raymond James names Andrew Gitkin as co-head of health care investment banking

Raymond James names Dane Leone as a managing director in biotech research

General

More